Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Leora Boussi, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Whitledge JD, Watson CJ, Simpson M, Bakkar A, Boussi L, Scott M, Boyle KL. Diphenhydramine-Induced Antimuscarinic Delirium Treated with Physostigmine and Transdermal Rivastigmine. J Med Toxicol. 2022 Dec 27. PMID: 36575250.
    Citations:    Fields:    
  2. Boussi LS, Avigan ZM, Rosenblatt J. Immunotherapy for the treatment of multiple myeloma. Front Immunol. 2022; 13:1027385. PMID: 36389674; PMCID: PMC9649817.
    Citations:    Fields:    Translation:Humans
  3. Shafagati N, Koh MJ, Boussi L, Park HJ, Stuver R, Bain P, Foss FM, Shen C, Jain S. Comparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas: a meta-analysis. Blood Adv. 2022 08 23; 6(16):4740-4762. PMID: 35816645; PMCID: PMC9631658.
    Citations:    Fields:    
  4. Russell BM, Boussi L, Bellmunt J. Management of Advanced Urothelial Carcinoma in Older and Frail Patients: Have Novel Treatment Approaches Improved Their Care? Drugs Aging. 2022 04; 39(4):271-284. PMID: 35344197.
    Citations:    Fields:    Translation:Humans
  5. Forsberg PA, Rossi AC, Boyer A, Pearse RN, Pekle KA, Jayabalan D, Lakritz S, Flicker K, Ribadeneyra D, Liotta B, Ely S, Boussi L, Allan JN, Coleman M, Niesvizky R, Mark TM. Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myeloma. Am J Hematol. 2021 12 01; 96(12):1554-1562. PMID: 34424561.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  6. Boussi L, Frishman WH. ß-Arrestin as a Therapeutic Target in Heart Failure. Cardiol Rev. 2021 Sep-Oct 01; 29(5):223-229. PMID: 33093306.
    Citations:    Fields:    Translation:HumansCells
  7. Boussi LS, Popli T, Feola N, Nog R. Clinical and microbiological characteristics of patients with bacteremia and normal procalcitonin. Diagn Microbiol Infect Dis. 2021 Dec; 101(4):115515. PMID: 34547664.
    Citations:    Fields:    Translation:HumansCells
  8. Boussi L, Safaya A, Goyal A, Mateo R, Laskowski I, Babu S. "Inflammatory Bowel Disease-Not Just the Bowel's Bane": Peripheral Arterial and Venous Thrombosis in a Patient With Crohn Disease. Vasc Endovascular Surg. 2020 Oct; 54(7):646-649. PMID: 32638640.
    Citations: 1     Fields:    Translation:Humans
  9. Forsberg PA, Rossi AC, Boyer A, Tegnestam L, Pearse RN, Perry A, Pekle KA, Jayabalan D, Ely S, Boussi L, Sherbenou DW, Williams C, Allan JN, Coleman M, Niesvizky R, Mark TM. Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma. Am J Hematol. 2019 05; 94(5):539-545. PMID: 30740766.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  10. Boussi L, Niesvizky R. Advances in immunotherapy in multiple myeloma. Curr Opin Oncol. 2017 Nov; 29(6):460-466. PMID: 28877078.
    Citations: 8     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Boussi's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (44)
Co-Authors (8)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.